POLYMEDNSEPoly Medicure Limited· PharmaceuticalsMediumNeutral
Announced Mon, 1 Jun · 18:54 IST

Poly Medicure Limited has informed the Exchange regarding Appointment of Mr. Indranil Mukherjee as Chief Executive Officer Asia Pacific and India Business, Senior Management Personnel of the company w.e.f. Jun 01, 2026.

Management Changes View source PDF

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹1325.00
prior close
₹1323.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.4-0.9-0.9+1.3+6.8+7.2+4.5+10.7+12.1+24.6+30.9
Up moveDown movePending
AI summary

Poly Medicure Limited has informed the stock exchange about the appointment of Mr. Indranil Mukherjee as Chief Executive Officer for the Asia Pacific and India Business, classified as a Senior Management Personnel. The appointment is effective from June 1, 2026. The announcement is a standard disclosure about a key leadership addition to the company's management team. No other details about his background or the reason for the appointment have been provided in the filing.

Likely market impact

This is a routine leadership appointment disclosure with no immediate financial impact on shareholders. Investors may want to track Mr. Mukherjee's performance in the new role once he takes charge, as the CEO of a key region can influence the company's growth trajectory in Asia Pacific and India markets.